Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02005510 · ClinicalTrials.gov registry record · NA
Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 19,851
- Enrollment target
NCT02005510 is a NA study that has completed, run by University of Washington. The registered enrollment target is 19,851 participants.
The verdict
NCT02005510, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 19,851 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine whether mailing in-home human papillomavirus (HPV) screening kits is effective in increasing uptake of cervical cancer screening and early detection and treatment of cervical neoplasia in underscreened women.
Interventions
- OTHER Usual care
- BEHAVIORAL Mailed in-home high-risk HPV testing kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19,851 participants |
| Start Date | 2014-02 |
| Est. Completion | 2018-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02005510
The ClinicalTrials.gov registry entry for NCT02005510 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19,851 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT02005510 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02005510 about?
NCT02005510 is a clinical study titled "Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women". The purpose of this trial is to determine whether mailing in-home human papillomavirus (HPV) screening kits is effective in increasing uptake of cervical cancer screening and early detection and treatment of cervical neoplasia in underscreened women.
What is the current status of trial NCT02005510?
This trial is currently completed. It is a NA study. The enrollment target is 19,851 participants. The study started on 2014-02. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02005510?
The interventions under investigation include: Usual care (OTHER), Mailed in-home high-risk HPV testing kit (BEHAVIORAL).
Who is sponsoring clinical trial NCT02005510?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.